Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials–Process Perspective

Abstract

Three dimensional (3D) printing as an advanced manufacturing technology is progressing to be established in the pharmaceutical industry to overcome the traditional manufacturing regime of 'one size fits for all'. Using 3D printing, it is possible to design and develop complex dosage forms that can be suitable for tuning drug release. Polymers are the key materials that are necessary for 3D printing. Among all 3D printing processes, extrusion-based (both fused deposition modeling (FDM) and pressure-assisted microsyringe (PAM)) 3D printing is well researched for pharmaceutical manufacturing. It is important to understand which polymers are suitable for extrusion-based 3D printing of pharmaceuticals and how their properties, as well as the behavior of polymer–active pharmaceutical ingredient (API) combinations, impact the printing process. Especially, understanding the rheology of the polymer and API–polymer mixtures is necessary for successful 3D printing of dosage forms or printed structures. This review has summarized a holistic materials–process perspective for polymers on extrusion-based 3D printing. The main focus herein will be both FDM and PAM 3D printing processes. It elaborates the discussion on the comparison of 3D printing with the traditional direct compression process, the necessity of rheology, and the characterization techniques required for the printed structure, drug, and excipients. The current technological challenges, regulatory aspects, and the direction toward which the technology is moving, especially for personalized pharmaceuticals and multi-drug printing, are also briefly discussed.

References 182

1. 1.

   Ligon S.C., Liska R., Stampfl J., Gurr M., Mülhaupt R. Polymers for 3D printing and customized additive manufacturing. Chem. Rev. 2017;117:10212-10290.

   Not in our library10.1021/acs.chemrev.7b00074

2. 2.

   Hofmann M. 3D printing gets a boost and opportunities with polymer materials. ACS Macro Lett. 2014;3:382-386.

   Not in our library10.1021/mz4006556

3. 3.

   Vikram Singh A., Hasan Dad Ansari M., Wang S., Laux P., Luch A., Kumar A., Patil R., Nussberger S. The Adoption of Three-Dimensional Additive Manufacturing from Biomedical Material Design to 3D Organ Printing. Appl. Sci. 2019;9:811.

   Not in our library10.3390/app9040811

4. 4.

   Norman J., Madurawe R.D., Moore C.M., Khan M.A., Khairuzzaman A. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Adv. Drug Deliv. Rev. 2017;108:39-50.

   Not in our library10.1016/j.addr.2016.03.001

5. 5.

   Liaw C.-Y., Guvendiren M. Current and emerging applications of 3D printing in medicine. Biofabrication. 2017;9:024102.

   Not in our library10.1088/1758-5090/aa7279

6. 6.

   Yoo J., Bradbury T.J., Bebb T.J., Iskra J., Surprenant H.L., West T.G. Three-Dimensional Printing System and Equipment Assembly. U.S. Patent. 2014.

   Not in our library

7. 7.

   Ginsburg G.S., McCarthy J.J. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol. 2001;19:491-496.

   Not in our library10.1016/s0167-7799(01)01814-5

8. 8.

   Schork N.J. Personalized medicine: Time for one-person trials. Nature. 2015;520:609-611.

   Not in our library10.1038/520609a

9. 9.

   Yu D.G., Zhu L.-M., Branford-White C.J., Yang X.L. Three-Dimensional Printing in Pharmaceutics: Promises and Problems. J. Pharm. Sci. 2008;97:3666-3690.

   Not in our library10.1002/jps.21284

10. 10.

    Sachs E., Cima M., Williams P., Brancazio D., Cornie J. Three dimensional printing: Rapid tooling and prototypes directly from a CAD model. J. Manuf. Sci. Eng. 1992;114:481-488.

    Not in our library10.1115/1.2900701

11. 11.

    Goole J., Amighi K. 3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. Int. J. Pharm. 2016;499:376-394.

    Not in our library10.1016/j.ijpharm.2015.12.071

12. 12.

    Wu B.M., Borland S.W., Giordano R.A., Cima L.G., Sachs E.M., Cima M.J. Solid free-form fabrication of drug delivery devices. J. Control. Release. 1996;40:77-87.

    Not in our library10.1016/0168-3659(95)00173-5

13. 13.

    Rowe C., Katstra W., Palazzolo R., Giritlioglu B., Teung P., Cima M. Multimechanism oral dosage forms fabricated by three dimensional printing™. J. Control. Release. 2000;66:11-17.

    Not in our library10.1016/s0168-3659(99)00224-2

14. 14.

    Wang C.-C., Tejwani M.R., Roach W.J., Kay J.L., Yoo J., Surprenant H.L., Monkhouse D.C., Pryor T.J. Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology. Drug Dev. Ind. Pharm. 2006;32:367-376.

    Not in our library10.1080/03639040500519300

15. 15.

    Yu D.G., Yang X.L., Huang W.D., Liu J., Wang Y.G., Xu H. Tablets with material gradients fabricated by three-dimensional printing. J. Pharm. Sci. 2007;96:2446-2456.

    Not in our library10.1002/jps.20864

16. 16.

    Infanger S., Haemmerli A., Iliev S., Baier A., Stoyanov E., Quodbach J. Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder. Int. J. Pharm. 2019;555:198-206.

    Not in our library10.1016/j.ijpharm.2018.11.048

17. 17.

    Khaled S.A., Burley J.C., Alexander M.R., Roberts C.J. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 2014;461:105-111.

    Not in our library10.1016/j.ijpharm.2013.11.021

18. 18.

    Khaled S.A., Burley J.C., Alexander M.R., Yang J., Roberts C.J. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J. Control. Release. 2015;217:308-314.

    Not in our library10.1016/j.jconrel.2015.09.028

19. 19.

    Goyanes A., Buanz A.B., Hatton G.B., Gaisford S., Basit A.W. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets. Eur. J. Pharm. Biopharm. 2015;89:157-162.

    Not in our library10.1016/j.ejpb.2014.12.003

20. 20.

    Pietrzak K., Isreb A., Alhnan M.A. A flexible-dose dispenser for immediate and extended release 3D printed tablets. Eur. J. Pharm. Biopharm. 2015;96:380-387.

    Not in our library10.1016/j.ejpb.2015.07.027

21. 21.

    Chen D., Xu X.-Y., Li R., Zang G.-A., Zhang Y., Wang M.-R., Xiong M.-F., Xu J.-R., Wang T., Fu H., et al. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages. AAPS PharmSciTech. 2020;21:6.

    Not in our library10.1208/s12249-019-1521-x

22. 22.

    Alhijjaj M., Nasereddin J., Belton P., Qi S. Impact of Processing Parameters on the Quality of Pharmaceutical Solid Dosage Forms Produced by Fused Deposition Modeling (FDM). Pharmaceutics. 2019;11:633.

    Not in our library10.3390/pharmaceutics11120633

23. 23.

    Eleftheriadis G.K., Ritzoulis C., Bouropoulos N., Tzetzis D., Andreadis D.A., Boetker J., Rantanen J., Fatouros D.G. Unidirectional drug release from 3D printed mucoadhesive buccal films using FDM technology: In vitro and ex vivo evaluation. Eur. J. Pharm. Biopharm. 2019;144:180-192.

    Not in our library10.1016/j.ejpb.2019.09.018

24. 24.

    Viidik L., Seera D., Antikainen O., Kogermann K., Heinämäki J., Laidmäe I. 3D-printability of aqueous poly(ethylene oxide) gels. Eur. Polym. J. 2019;120:109206.

    Not in our library10.1016/j.eurpolymj.2019.08.033

25. 25.

    Feuerbach T., Callau-Mendoza S., Thommes M. Development of filaments for fused deposition modeling 3D printing with medical grade poly(lactic-co-glycolic acid) copolymers. Pharm. Dev. Technol. 2018;24:487-493.

    Not in our library10.1080/10837450.2018.1514522

26. 26.

    Nukala P.K., Palekar S., Patki M., Patel K. Abuse Deterrent Immediate Release Egg-Shaped Tablet (Egglets) Using 3D Printing Technology: Quality by Design to Optimize Drug Release and Extraction. AAPS PharmSciTech. 2019;20:80.

    Not in our library10.1208/s12249-019-1298-y

27. 27.

    Healy A.V., Fuenmayor E., Doran P., Geever L.M., Higginbotham C.L., Lyons J.G. Additive Manufacturing of Personalized Pharmaceutical Dosage Forms via Stereolithography. Pharmaceutics. 2019;11:645.

    Not in our library10.3390/pharmaceutics11120645

28. 28.

    Martinez P.R., Goyanes A., Basit A.W., Gaisford S. Influence of Geometry on the Drug Release Profiles of Stereolithographic (SLA) 3D-Printed Tablets. AAPS PharmSciTech. 2018;19:3355-3361.

    Not in our library10.1208/s12249-018-1075-3

29. 29.

    Wang J., Goyanes A., Gaisford S., Basit A.W. Stereolithographic (SLA) 3D printing of oral modified-release dosage forms. Int. J. Pharm. 2016;503:207-212.

    Not in our library10.1016/j.ijpharm.2016.03.016

30. 30.
    3D Printed Pellets (Miniprintlets): A Novel, Multi-Drug, Controlled Release Platform Technology · 2019

    No notice
31. 31.

    Fina F., Madla C.M., Goyanes A., Zhang J., Gaisford S., Basit A.W. Fabricating 3D printed orally disintegrating printlets using selective laser sintering. Int. J. Pharm. 2018;541:101-107.

    Not in our library10.1016/j.ijpharm.2018.02.015

32. 32.

    Fina F., Goyanes A., Gaisford S., Basit A.W. Selective laser sintering (SLS) 3D printing of medicines. Int. J. Pharm. 2017;529:285-293.

    Not in our library10.1016/j.ijpharm.2017.06.082

33. 33.

    Kyobula M., Adedeji A., Alexander M.R., Saleh E., Wildman R., Ashcroft I., Gellert P.R., Roberts C.J. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. J. Control. Release. 2017;261:207-215.

    Not in our library10.1016/j.jconrel.2017.06.025

34. 34.

    Clark E.A., Alexander M.R., Irvine D.J., Roberts C.J., Wallace M.J., Sharpe S., Yoo J., Hague R.J.M., Tuck C.J., Wildman R.D. 3D printing of tablets using inkjet with UV photoinitiation. Int. J. Pharm. 2017;529:523-530.

    Not in our library10.1016/j.ijpharm.2017.06.085

35. 35.

    Cader H.K., Rance G.A., Alexander M.R., Gonçalves A.D., Roberts C.J., Tuck C.J., Wildman R.D. Water-based 3D inkjet printing of an oral pharmaceutical dosage form. Int. J. Pharm. 2019;564:359-368.

    Not in our library10.1016/j.ijpharm.2019.04.026

36. 36.

    Kadry H., Wadnap S., Xu C., Ahsan F. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur. J. Pharm. Sci. 2019;135:60-67.

    Not in our library10.1016/j.ejps.2019.05.008

37. 37.

    Krkobabić M., Medarević D., Cvijić S., Grujić B., Ibrić S. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate. Int. J. Pharm. 2019;572:118790.

    Not in our library10.1016/j.ijpharm.2019.118790

38. 38.

    Goyanes A., Buanz A.B., Basit A.W., Gaisford S. Fused-filament 3D printing (3DP) for fabrication of tablets. Int. J. Pharm. 2014;476:88-92.

    Not in our library10.1016/j.ijpharm.2014.09.044

39. 39.

    Godwin A., Bolina K., Clochard M., Dinand E., Rankin S., Simic S., Brocchini S. New strategies for polymer development in pharmaceutical science—A short review. J. Pharm. Pharmacol. 2001;53:1175-1184.

    Not in our library10.1211/0022357011776612

40. 40.

    Jones D.S. Pharmaceutical Applications of Polymers for Drug Delivery. 2004.

    Not in our library

Cited by papers we hold 2

• 3D-printed drug delivery system from food waste: A sustainable approach for the development of novel drug delivery systems · 2025
  Not checked
• 3D Printing as a Promising Tool in Personalized Medicine · 2021
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.